Similar articles for PMID: 25332316

Year	Number of Results
1949	1
1966	1
1970	1
1986	1
1988	1
1993	1
1994	1
1996	2
1998	1
1999	1
2003	6
2005	2
2006	3
2007	1
2008	2
2009	10
2010	5
2011	10
2012	12
2013	16
2014	17
2015	22
2016	13
2017	18
2018	9
2019	9
2020	10
2021	1

1

Association of indoxyl sulfate with heart failure among patients on hemodialysis.

Cao XS, Chen J, Zou JZ, Zhong YH, Teng J, Ji J, Chen ZW, Liu ZH, Shen B, Nie YX, Lv WL, Xiang FF, Tan X, Ding XQ. Cao XS, et al. Clin J Am Soc Nephrol. 2015 Jan 7;10(1):111-9. doi: 10.2215/CJN.04730514. Epub 2014 Oct 20. Clin J Am Soc Nephrol. 2015. PMID: 25332316 Free PMC article.

2

Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.

Wang CH, Cheng ML, Liu MH, Shiao MS, Hsu KH, Huang YY, Lin CC, Lin JF. Wang CH, et al. Heart Vessels. 2016 Jul;31(7):1100-8. doi: 10.1007/s00380-015-0702-0. Epub 2015 Jul 2. Heart Vessels. 2016. PMID: 26135926

3

Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.

Wu CC, Hsieh MY, Hung SC, Kuo KL, Tsai TH, Lai CL, Chen JW, Lin SJ, Huang PH, Tarng DC. Wu CC, et al. J Am Soc Nephrol. 2016 Apr;27(4):1254-64. doi: 10.1681/ASN.2015010068. Epub 2015 Oct 9. J Am Soc Nephrol. 2016. PMID: 26453609 Free PMC article.

4

Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.

Madero M, Cano KB, Campos I, Tao X, Maheshwari V, Brown J, Cornejo B, Handelman G, Thijssen S, Kotanko P. Madero M, et al. Clin J Am Soc Nephrol. 2019 Mar 7;14(3):394-402. doi: 10.2215/CJN.05240418. Epub 2019 Feb 12. Clin J Am Soc Nephrol. 2019. PMID: 30755453 Free PMC article.

5

Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease.

Lin CJ, Liu HL, Pan CF, Chuang CK, Jayakumar T, Wang TJ, Chen HH, Wu CJ. Lin CJ, et al. Arch Med Res. 2012 Aug;43(6):451-6. doi: 10.1016/j.arcmed.2012.08.002. Epub 2012 Aug 8. Arch Med Res. 2012. PMID: 22885091

6

Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.

Taki K, Tsuruta Y, Niwa T. Taki K, et al. Am J Nephrol. 2007;27(1):30-5. doi: 10.1159/000098542. Epub 2007 Jan 11. Am J Nephrol. 2007. PMID: 17215572

7

The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.

Lin CJ, Pan CF, Liu HL, Chuang CK, Jayakumar T, Wang TJ, Chen HH, Wu CJ. Lin CJ, et al. Atherosclerosis. 2012 Nov;225(1):173-9. doi: 10.1016/j.atherosclerosis.2012.07.012. Epub 2012 Aug 28. Atherosclerosis. 2012. PMID: 22981405

8

Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study.

Wang W, Hao G, Pan Y, Ma S, Yang T, Shi P, Zhu Q, Xie Y, Ma S, Zhang Q, Ruan H, Ding F. Wang W, et al. BMC Nephrol. 2019 Feb 14;20(1):57. doi: 10.1186/s12882-019-1238-9. BMC Nephrol. 2019. PMID: 30764800 Free PMC article.

9

Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.

Bataille S, Pelletier M, Sallée M, Berland Y, McKay N, Duval A, Gentile S, Mouelhi Y, Brunet P, Burtey S. Bataille S, et al. BMC Nephrol. 2017 Jul 26;18(1):251. doi: 10.1186/s12882-017-0668-5. BMC Nephrol. 2017. PMID: 28747155 Free PMC article.

10

p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Meijers BK, De Loor H, Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P. Meijers BK, et al. Clin J Am Soc Nephrol. 2009 Dec;4(12):1932-8. doi: 10.2215/CJN.02940509. Epub 2009 Oct 15. Clin J Am Soc Nephrol. 2009. PMID: 19833905 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed